Posted: 30 November 2023 Closes: 14 January 2024, 11:00pm AEST/AEDT Acknowledgement of Country CSIRO acknowledges the Traditional Owners of the land, sea and waters, of the area that we live and work on across Australia. We acknowledge their…
Posted: 10 November 2023 The company Our client is a Melbourne-based, ASX-listed biotechnology company, who has developed a polyclonal antibody platform and novel class of antibodies that can address unmet medical needs. The role Reporting to the Director…
Posted: 3 November 2023 Our Client Our client is a clinical-stage medical technology company developing a first-of-its-kind treatment. Their Board of Directors and management bring extensive operational and financial experience in medical technologies and life sciences, while its…
Posted: 27 September 2023 The Client Leveraging an experienced team of pharmaceutical industry professionals and biotech entrepreneurs to develop a promising, novel small-molecule drug candidate, our client is a UK-based biotech looking to expand their clinical program within…
Posted: 10 July 2023 Acknowledgement of Country CSIRO acknowledges the Traditional Owners of the land, sea and waters, of the area that we live and work on across Australia. We acknowledge their continuing connection to their culture and…